Dataiku
AI
Dataiku is the Platform for AI Success that unites people, orchestration, and governance to turn AI investments into measurable business outcomes.
Is Dataiku hiring?
Yes. As of October 5, 2026, Dataiku has 2 open roles on Metaintro.
Open roles
Newest first. Pay shown when the posting lists it.
Customers
All 5 companies Dataiku names as customers.
Customers5
- SSLB
- MMichelin
- TToyota
- NNovartis
- JJohnson & Johnson
AI launches and partners
What Dataiku has launched and who it works with on AI.
- LaunchCobuildDataiku's agentic interface lets users explore data, build governed AI, and oversee the agents they run in natural language across the whole platform.
- LaunchDataiku E2A (Expert-to-Agent)Dataiku E2A scales expertise with production-ready AI agents grounded in enterprise data, structured reasoning, and human oversight.
- LaunchDataiku LLM MeshThe Dataiku LLM Mesh connects to LLM providers or self-hosted models, with centralized visibility and control across connections.
- LaunchEnterprise machine learning platformDataiku provides a platform to build and evaluate machine learning models.
Skills they ask for
Most frequent across open postings.
Tech stack
- Marketing
- HubSpot
- Analytics
- Google Tag Manager
- Google Analytics 4
- Security
- OneTrust
- Libraries
- Tailwind CSS
- Frameworks
- Next.js
- CMS
- Contentful
- WordPress
Company facts
- Industry
- AI
- Sector (NAICS)
- Information
- Peer
- LangChain
- Website
- dataiku.com
- Careers
- dataiku.com/company/careers
Roles by location
Where Dataiku is hiring. Pick a city to see its roles.
Similar companies
Companies in the same industry as Dataiku that are hiring now.
Questions about Dataiku
- Is Dataiku hiring?
- Yes. As of October 5, 2026, Dataiku has 2 open roles on Metaintro. The most are in Human Resources/Talent Acquisition (1) and IT Training (1).
- Where is Dataiku hiring?
- Dataiku is hiring in Paris and Tokyo, with the most open roles in Paris.
- Who are Dataiku's customers?
- Dataiku names 5 customers, including SLB, Michelin, Toyota, Novartis, and Johnson & Johnson.